Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
14 auth. M. Reck, R. Kaiser, A. Mellemgaard, J. Douillard, S. Orlov, M. Krzakowski, J. von Pawel, M. Gottfried, I. Bondarenko, M. Liao, ... Claudia-Nanette Gann, J. Barrueco, B. Gaschler-Markefski, S. Novello